Gary B. Gordon Ayala Pharmaceuticals, Inc. (AYLA) insider trading activity

Gary B. Gordon is Chief Medical Officer of Ayala Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of AYLA, which is worth approximately $0. The most recent transaction as insider was on Jan 19, 2023, when has been sold 58,520 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Gary B. Gordon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 19 2023	SELL Sale (or disposition) back to the issuer	-	58,520 Reduced 100.0%	0 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	50,000 Added 46.07%	58,520 Common Stock
Feb 24 2021	SELL Open market or private sale	$52,380 $17.46 p/Share	3,000 Reduced 26.04%	8,520 Common Stock
Feb 24 2021	BUY Exercise of conversion of derivative security	$15,480 $5.16 p/Share	3,000 Added 20.66%	11,520 Common Stock
Jan 20 2021	SELL Open market or private sale	$45,090 $15.03 p/Share	3,000 Reduced 26.04%	8,520 Common Stock
Jan 20 2021	BUY Exercise of conversion of derivative security	$15,480 $5.16 p/Share	3,000 Added 20.66%	11,520 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	8,520 Added 50.0%	8,520 Common Stock

GBG

Gary B. Gordon

Chief Medical Officer

Rehovot, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AYLA shares.

Notify only if

Value

Insider Trading

Get notified when an Ayala Pharmaceuticals, Inc. insider buys or sells AYLA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ayala Pharmaceuticals, Inc.

Track Activities on AYLA

Account